Full video transcriptClick to expand
Auto-generated transcript of @itsourremedy's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I'm a week into my testosterone now and I'm sat here thinking I didn't go to the doctors because
- 0:05I had low sex drive. I didn't think. That wasn't my problem. My problem was like lack of energy,
- 0:11motivation, focus, this brain fog. It turns out that increased drive is a very welcome
- 0:20side effect so far. Teenage boy. In the UK we can only be prescribed testosterone if we have a
- 0:26low sex drive as women. Let you know now that if you don't feel like you have one so you don't
- 0:32feel like you can say that you might have one but not even know it because without this you didn't
- 0:37know because I did not know. I mean it's a very welcome side effect like I say but I wouldn't have
- 0:43thought I had this problem until now I'm feeling this way. I don't know if that makes sense 21
- 0:49but I just thought I'd put it out there anyway. I have got a testosterone playlist about HRT,
- 0:54testosterone so if you want to go check that out I'll tag this one in it as well so you can look
- 0:58at more stuff about it and let me know in the comments if this has been a very pleasant side
- 1:02effect for you as well because I've got to say it's a nice feeling to have this feeling.
Testosterone and libido in women: what the evidence actually shows
Quick answer
The creator began testosterone therapy for fatigue, cognitive symptoms, and low motivation, not low libido, and reports an unexpected increase in sexual desire within one week of starting treatment. Testosterone's role in female sexual function is supported by level 1 evidence for hypoactive sexual desire disorder, though early onset of effects at one week is faster than most clinical trial timelines suggest. In the UK, testosterone is prescribed off-label for women, and access is inconsistently tied to self-reported libido complaints despite broader NICE guidance supporting its use.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Testosterone and libido in women: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Testosterone and libido in women: what the evidence actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Testosterone and libido in women: what the evidence actually shows" from Our Remedy. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator began testosterone therapy for fatigue, cognitive symptoms, and low motivation, not low libido, and reports an unexpected increase in sexual desire within one week of starting treatment.
The reason this review is not generic is the source wording and the canonical claim label "trt has this happened to you testosterone for women and increase." In this clip, the useful excerpt is: "I'm a week into my testosterone now and I'm sat here thinking I didn't go to the doctors because I had low sex drive." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator began testosterone therapy for fatigue, cognitive symptoms, and low motivation, not low libido, and reports an unexpected increase in sexual desire within one week of starting treatment.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator began testosterone therapy for fatigue, cognitive symptoms, and low motivation, not low libido, and reports an unexpected increase in sexual desire within one week of starting treatment. Testosterone's role in female sexual function is supported by level 1 evidence for hypoactive sexual desire disorder, though early onset of effects at one week is faster than most clinical trial timelines suggest. In the UK, testosterone is prescribed off-label for women, and access is inconsistently tied to self-reported libido complaints despite broader NICE guidance supporting its use.
- A 2019 Global Consensus Statement (Davis et al., Journal of Clinical Endocrinology and Metabolism) confirmed level 1 evidence for testosterone improving sexual desire in postmenopausal women, making her reported effect scientifically plausible.
- Testosterone is not licensed for women in the UK and must be prescribed off-label. NICE guideline NG23 supports this use, but access varies widely by prescriber and region.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- A 2019 Global Consensus Statement (Davis et al., Journal of Clinical Endocrinology and Metabolism) confirmed level 1 evidence for testosterone improving sexual desire in postmenopausal women, making her reported effect scientifically plausible.
- Testosterone is not licensed for women in the UK and must be prescribed off-label. NICE guideline NG23 supports this use, but access varies widely by prescriber and region.
- One week is faster than most clinical trial timelines for measuring testosterone's sexual effects. Early changes may involve mood or expectation rather than direct hormonal action on libido.
- Women with hypoactive sexual desire disorder frequently do not self-identify as having reduced libido. Simon et al. (2016) found this underrecognition is common, supporting her claim that the problem can be invisible until reversed.
- Testosterone in women requires careful dose monitoring. Excess dosing can cause permanent side effects including voice deepening and clitoral enlargement, which is why she should be working with a clinician who tracks bloodwork.
- Fatigue, brain fog, and motivation problems overlap with thyroid disorders, iron deficiency anemia, and depression. Testosterone is not the automatic answer for these symptoms, and baseline testing before starting therapy matters.
- The British Menopause Society supports testosterone access for women with appropriate indications beyond libido alone, meaning women denied a prescription solely on symptom gatekeeping grounds can seek a second opinion from a menopause specialist.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @itsourremedy actually say?
She started testosterone for energy, brain fog, and motivation, not low libido. One week in, she noticed a significant increase in sex drive that she describes as "a very welcome side effect." She also flags a specific UK regulatory issue: women in the UK can only be prescribed testosterone if low libido is listed as a symptom, which she finds absurd given her own experience.
Her core point is honest and worth taking seriously. She's saying she didn't know she had reduced libido until testosterone restored it, which is a genuinely underreported phenomenon. She's not selling anything. She's sharing a lived experience with a drug she's one week into. That context matters when evaluating the claims.
Does the science back this up?
Yes, with some nuance. Testosterone does have evidence behind it for libido in women, particularly those in menopause or perimenopause. The mechanism isn't fully understood, but it's real enough that it earned a position statement from multiple endocrinology bodies.
The 2019 Global Consensus Position Statement on the Use of Testosterone Therapy for Women, published in the Journal of Clinical Endocrinology and Metabolism (Davis et al., 2019), concluded there is level 1 evidence supporting testosterone therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal women. That's not a minor endorsement. Level 1 means randomized controlled trials exist.
Her observation that she didn't know she had low libido until it changed is also consistent with how HSDD presents clinically. The condition is often described as an absence that women don't notice until they have a baseline to compare against. A 2016 study by Simon et al. in Menopause noted that many women with HSDD don't self-identify as having a sexual problem, partly because reduced desire can feel like a new normal.
What did they get wrong (or right)?
She got the core experience right. Testosterone affecting libido within days to a couple of weeks is plausible, though the pharmacokinetics suggest early effects are more likely driven by expectation and mood lift than by tissue-level hormonal changes. Most studies measure outcomes over 12-24 weeks.
The UK prescribing claim needs more precision. She says women in the UK "can only be prescribed testosterone if we have a low sex drive." This is approximately true but slightly oversimplified. NHS England does not license testosterone for women at all. Testogel and other formulations are prescribed off-label, and NICE guidance (NG23, updated 2024) supports testosterone for women with low sexual desire after discussing risks and benefits. The de facto gatekeeping she describes is real, but it's a clinical culture problem, not strictly a legal one.
She didn't make any dangerous claims. She didn't recommend a dose. She didn't suggest others self-prescribe. Credit where it's due.
What should you actually know?
If you're a woman experiencing low energy, brain fog, or motivation changes, testosterone is not automatically the answer, but it's a legitimate clinical conversation to have. These symptoms overlap with thyroid dysfunction, iron deficiency, depression, and perimenopause itself, so proper testing before starting any hormone therapy matters.
The libido effect she's describing is documented but not guaranteed. Davis et al. (2019) found statistically significant improvements in sexual function scores compared to placebo, but response varies. Some women notice nothing. The "teenage boy" comparison she makes is funny, but also a reminder that dosing in women requires careful monitoring. Too much testosterone causes acne, hair loss, voice changes, and clitoral enlargement that may be permanent.
On the prescribing issue: if you live in the UK and are being denied testosterone because you ticked the wrong symptom box, that's worth pushing back on with a GP or seeking a second opinion through a menopause specialist. The British Menopause Society supports access to testosterone for appropriate candidates beyond just libido complaints.
The bottom line
This video is largely credible. She's describing a documented side effect of testosterone therapy, flagging a genuine access problem in UK prescribing, and doing it without overclaiming. The science supports the libido connection. Her one-week timeline for noticing changes is early, and the mechanisms at that stage are murky, but the effect itself is real and well-documented in the literature. Her broader point, that women may not know what they're missing until they have it back, is worth a wider conversation than TikTok usually allows.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Our Remedy · TikTok creator
115.3K views on this video
Has this happened to you? Testosterone for women and increased libido! #hrt #libido #hormonereplacementtherapy #menopause #perimenopause #earlymenopause #testosterone
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about a 2019 global consensus statement (davis et al., journal of?
A 2019 Global Consensus Statement (Davis et al., Journal of Clinical Endocrinology and Metabolism) confirmed level 1 evidence for testosterone improving sexual desire in postmenopausal women, making her reported effect scientifically plausible.
What does the video say about testosterone?
Testosterone is not licensed for women in the UK and must be prescribed off-label. NICE guideline NG23 supports this use, but access varies widely by prescriber and region.
What does the video say about one week?
One week is faster than most clinical trial timelines for measuring testosterone's sexual effects. Early changes may involve mood or expectation rather than direct hormonal action on libido.
What does the video say about women with hypoactive sexual desire disorder frequently do not self-identify?
Women with hypoactive sexual desire disorder frequently do not self-identify as having reduced libido. Simon et al. (2016) found this underrecognition is common, supporting her claim that the problem can be invisible until reversed.
What does the video say about testosterone in women requires careful dose monitoring. excess dosing can?
Testosterone in women requires careful dose monitoring. Excess dosing can cause permanent side effects including voice deepening and clitoral enlargement, which is why she should be working with a clinician who tracks bloodwork.
What does the video say about fatigue, brain fog,?
Fatigue, brain fog, and motivation problems overlap with thyroid disorders, iron deficiency anemia, and depression. Testosterone is not the automatic answer for these symptoms, and baseline testing before starting therapy matters.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Our Remedy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.